Chofu, Japan

Kazumi Katagiri

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Fbc (Shanghai) Pharmaceutical Technology Co., Ltd., Kewpie Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazumi Katagiri. Retrieved from https://idiyas.com/inventor/kazumi-katagiri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazumi Katagiri: Innovator in Emulsion Technology

Introduction

Kazumi Katagiri is a notable inventor based in Chofu, Japan. She has made significant contributions to the field of emulsion technology, particularly in the pharmaceutical sector. Her innovative work has led to the development of a unique emulsion formulation that has potential applications in medicine.

Latest Patents

Kazumi Katagiri holds a patent for an emulsion that includes aprepitant, an emulsifier, an oil, polyethylene glycol, and water, without substantial addition of ethanol. This invention is aimed at improving the delivery and effectiveness of pharmaceutical agents.

Career Highlights

Throughout her career, Katagiri has worked with prominent companies such as Kewpie Corporation and FBC (Shanghai) Pharmaceutical Technology Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to advancements in emulsion technology.

Collaborations

Kazumi Katagiri has collaborated with various professionals in her field, including her coworker Yohei Amano. Their partnership has fostered innovation and development in their respective projects.

Conclusion

Kazumi Katagiri's contributions to emulsion technology highlight her role as a pioneering inventor. Her patent and collaborations reflect her commitment to advancing pharmaceutical formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…